China-listed vaccine-theme ETFs surged at the open, with Penghua and China Merchants vaccine ETFs hitting limit-up, Harvest and Fullgoal each rising over 9%, and Guotai rising over 7%, following Merck (MRK) and Moderna (MRNA) announcing positive preliminary results from their first late-stage clinical trial of a melanoma skin-cancer vaccine.
Jin1008/20, 08:28 AM
China-listed vaccine-theme ETFs surged limit-up or near limit-up on August 20, after Merck (MRK) and Moderna (MRNA) announced positive preliminary results from their first late-stage clinical trial of a melanoma skin-cancer vaccine.
Related assets
Coming up for MRK
Explore next
Latest MRK news
Jin1010/23, 12:41 AM
Jin1008/21, 09:26 PM
Merck (MRK) stock rose 3.7% intraday, breaking above Wednesday's record high.
Finnhub08/20, 08:06 PM